|
C13ORF31 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.079620E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.017240E-01 |
| Normal-vs-Stage2 |
7.720400E-02 |
| Normal-vs-Stage3 |
9.957900E-02 |
| Normal-vs-Stage4 |
1.400140E-03 |
| Stage1-vs-Stage2 |
2.433000E-01 |
| Stage1-vs-Stage3 |
7.817700E-03 |
| Stage1-vs-Stage4 |
4.62420000002517E-06 |
| Stage2-vs-Stage3 |
1.358350E-02 |
| Stage2-vs-Stage4 |
9.168600E-04 |
| Stage3-vs-Stage4 |
7.646500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.769950E-01 |
| Normal-vs-AfricanAmerican |
2.572200E-01 |
| Normal-vs-Asian |
7.371600E-01 |
| Caucasian-vs-AfricanAmerican |
8.212400E-01 |
| Caucasian-vs-Asian |
4.194200E-01 |
| AfricanAmerican-vs-Asian |
4.508400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.091210E-01 |
| Normal-vs-Female |
2.925600E-01 |
| Male-vs-Female |
9.776600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.386600E-01 |
| Normal-vs-Extreme_Weight |
6.322800E-01 |
| Normal-vs-Obese |
2.321800E-01 |
| Normal-vs-Extreme_Obese |
9.891400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.884600E-01 |
| Normal_Weight-vs-Obese |
5.341000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.680200E-01 |
| Extreme_Weight-vs-Obese |
3.873600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.160600E-01 |
| Obese-vs-Extreme_Obese |
5.619000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.442600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.932300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.626440E-01 |
| Normal-vs-Age(81-100Yrs) |
5.954200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.038700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.239800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.619900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.876600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.885500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.342170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.980400E-02 |
| Normal-VS-Type2 PRCC |
2.758800E-01 |
| Normal-VS-KIRP CIMP |
3.174699999553E-07 |
| Normal-VS-Unclassified PRCC |
2.231600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.282200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.14930004297054E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.573360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.23209997759943E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.245390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.95619997767471E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.971400E-01 |
| Normal-vs-N1 |
7.572500E-04 |
| Normal-vs-N2 |
4.118600E-03 |
| N0-vs-N1 |
5.590800E-04 |
| N0-vs-N2 |
7.16990000038109E-07 |
| N1-vs-N2 |
2.545800E-01 |
|
|
